United States Reverse Transcriptase Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Reverse Transcriptase Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Reverse Transcriptase Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Reverse Transcriptase Overall Market Size
2.1 United States Reverse Transcriptase Market Size: 2021 VS 2027
2.2 United States Reverse Transcriptase Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Reverse Transcriptase Sales: 2016-2027
3 Company Landscape
3.1 Top Reverse Transcriptase Players in United States Market
3.2 Top United States Reverse Transcriptase Companies Ranked by Revenue
3.3 United States Reverse Transcriptase Revenue by Companies
3.4 United States Reverse Transcriptase Sales by Companies
3.5 United States Reverse Transcriptase Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Reverse Transcriptase Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Reverse Transcriptase Product Type
3.8 Tier 1, Tier 2 and Tier 3 Reverse Transcriptase Players in United States Market
3.8.1 List of Tier 1 Reverse Transcriptase Companies in United States
3.8.2 List of Tier 2 and Tier 3 Reverse Transcriptase Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Reverse Transcriptase Market Size Markets, 2021 & 2027
4.1.2 MMLV Reverse Transcriptase
4.1.3 AMV Reverse Transcriptase
4.2 By Type - United States Reverse Transcriptase Revenue & Forecasts
4.2.1 By Type - United States Reverse Transcriptase Revenue, 2016-2021
4.2.2 By Type - United States Reverse Transcriptase Revenue, 2022-2027
4.2.3 By Type - United States Reverse Transcriptase Revenue Market Share, 2016-2027
4.3 By Type - United States Reverse Transcriptase Sales & Forecasts
4.3.1 By Type - United States Reverse Transcriptase Sales, 2016-2021
4.3.2 By Type - United States Reverse Transcriptase Sales, 2022-2027
4.3.3 By Type - United States Reverse Transcriptase Sales Market Share, 2016-2027
4.4 By Type - United States Reverse Transcriptase Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Reverse Transcriptase Market Size, 2021 & 2027
5.1.2 PCR
5.1.3 Sequencing
5.1.4 Cloning
5.2 By Application - United States Reverse Transcriptase Revenue & Forecasts
5.2.1 By Application - United States Reverse Transcriptase Revenue, 2016-2021
5.2.2 By Application - United States Reverse Transcriptase Revenue, 2022-2027
5.2.3 By Application - United States Reverse Transcriptase Revenue Market Share, 2016-2027
5.3 By Application - United States Reverse Transcriptase Sales & Forecasts
5.3.1 By Application - United States Reverse Transcriptase Sales, 2016-2021
5.3.2 By Application - United States Reverse Transcriptase Sales, 2022-2027
5.3.3 By Application - United States Reverse Transcriptase Sales Market Share, 2016-2027
5.4 By Application - United States Reverse Transcriptase Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Thermo Fisher
6.1.1 Thermo Fisher Corporation Information
6.1.2 Thermo Fisher Overview
6.1.3 Thermo Fisher Reverse Transcriptase Sales and Revenue in United States Market (2016-2021)
6.1.4 Thermo Fisher Reverse Transcriptase Product Description
6.1.5 Thermo Fisher Recent Developments
6.2 Promega
6.2.1 Promega Corporation Information
6.2.2 Promega Overview
6.2.3 Promega Reverse Transcriptase Sales and Revenue in United States Market (2016-2021)
6.2.4 Promega Reverse Transcriptase Product Description
6.2.5 Promega Recent Developments
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Overview
6.3.3 Roche Reverse Transcriptase Sales and Revenue in United States Market (2016-2021)
6.3.4 Roche Reverse Transcriptase Product Description
6.3.5 Roche Recent Developments
6.4 Bio-Rad
6.4.1 Bio-Rad Corporation Information
6.4.2 Bio-Rad Overview
6.4.3 Bio-Rad Reverse Transcriptase Sales and Revenue in United States Market (2016-2021)
6.4.4 Bio-Rad Reverse Transcriptase Product Description
6.4.5 Bio-Rad Recent Developments
6.5 Takara Bio
6.5.1 Takara Bio Corporation Information
6.5.2 Takara Bio Overview
6.5.3 Takara Bio Reverse Transcriptase Sales and Revenue in United States Market (2016-2021)
6.5.4 Takara Bio Reverse Transcriptase Product Description
6.5.5 Takara Bio Recent Developments
6.6 Agilent
6.6.1 Agilent Corporation Information
6.6.2 Agilent Overview
6.6.3 Agilent Reverse Transcriptase Sales and Revenue in United States Market (2016-2021)
6.6.4 Agilent Reverse Transcriptase Product Description
6.6.5 Agilent Recent Developments
6.7 Qiagen
6.7.1 Qiagen Corporation Information
6.7.2 Qiagen Overview
6.7.3 Qiagen Reverse Transcriptase Sales and Revenue in United States Market (2016-2021)
6.7.4 Qiagen Reverse Transcriptase Product Description
6.7.5 Qiagen Recent Developments
6.8 Fapon Biotech
6.8.1 Fapon Biotech Corporation Information
6.8.2 Fapon Biotech Overview
6.8.3 Fapon Biotech Reverse Transcriptase Sales and Revenue in United States Market (2016-2021)
6.8.4 Fapon Biotech Reverse Transcriptase Product Description
6.8.5 Fapon Biotech Recent Developments
6.9 Toyobo
6.9.1 Toyobo Corporation Information
6.9.2 Toyobo Overview
6.9.3 Toyobo Reverse Transcriptase Sales and Revenue in United States Market (2016-2021)
6.9.4 Toyobo Reverse Transcriptase Product Description
6.9.5 Toyobo Recent Developments
6.10 Vazyme
6.10.1 Vazyme Corporation Information
6.10.2 Vazyme Overview
6.10.3 Vazyme Reverse Transcriptase Sales and Revenue in United States Market (2016-2021)
6.10.4 Vazyme Reverse Transcriptase Product Description
6.10.5 Vazyme Recent Developments
6.11 New England Biolabs
6.11.1 New England Biolabs Corporation Information
6.11.2 New England Biolabs Overview
6.11.3 New England Biolabs Reverse Transcriptase Sales and Revenue in United States Market (2016-2021)
6.11.4 New England Biolabs Reverse Transcriptase Product Description
6.11.5 New England Biolabs Recent Developments
7 United States Reverse Transcriptase Production Capacity, Analysis
7.1 United States Reverse Transcriptase Production Capacity, 2016-2027
7.2 Reverse Transcriptase Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Reverse Transcriptase Supply Chain Analysis
9.1 Reverse Transcriptase Industry Value Chain
9.2 Reverse Transcriptase Upstream Market
9.3 Reverse Transcriptase Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Reverse Transcriptase Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Reverse Transcriptase in United States Market
Table 2. Top Reverse Transcriptase Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Reverse Transcriptase Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Reverse Transcriptase Revenue Share by Companies, 2016-2021
Table 5. United States Reverse Transcriptase Sales by Companies, (L), 2016-2021
Table 6. United States Reverse Transcriptase Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Reverse Transcriptase Price (2016-2021) & (USD/ml)
Table 8. Manufacturers Reverse Transcriptase Product Type
Table 9. List of Tier 1 Reverse Transcriptase Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Reverse Transcriptase Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of MMLV Reverse Transcriptase
Table 12. Major Manufacturers of AMV Reverse Transcriptase
Table 13. By Type - United States Reverse Transcriptase Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Reverse Transcriptase Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Reverse Transcriptase Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Reverse Transcriptase Sales (L), 2016-2021
Table 17. By Type - United States Reverse Transcriptase Sales (L), 2022-2027
Table 18. By Application - United States Reverse Transcriptase Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Reverse Transcriptase Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Reverse Transcriptase Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Reverse Transcriptase Sales (L), 2016-2021
Table 22. By Application - United States Reverse Transcriptase Sales (L), 2022-2027
Table 23. Thermo Fisher Corporation Information
Table 24. Thermo Fisher Description and Major Businesses
Table 25. Thermo Fisher Reverse Transcriptase Sales (L), Revenue (US$, Mn) and Gross Margin (USD/ml) (2016-2021)
Table 26. Thermo Fisher Reverse Transcriptase Product
Table 27. Thermo Fisher Recent Developments
Table 28. Promega Corporation Information
Table 29. Promega Description and Major Businesses
Table 30. Promega Reverse Transcriptase Sales (L), Revenue (US$, Mn) and Gross Margin (USD/ml) (2016-2021)
Table 31. Promega Reverse Transcriptase Product
Table 32. Promega Recent Developments
Table 33. Roche Corporation Information
Table 34. Roche Description and Major Businesses
Table 35. Roche Reverse Transcriptase Sales (L), Revenue (US$, Mn) and Gross Margin (USD/ml) (2016-2021)
Table 36. Roche Reverse Transcriptase Product
Table 37. Roche Recent Developments
Table 38. Bio-Rad Corporation Information
Table 39. Bio-Rad Description and Major Businesses
Table 40. Bio-Rad Reverse Transcriptase Sales (L), Revenue (US$, Mn) and Gross Margin (USD/ml) (2016-2021)
Table 41. Bio-Rad Reverse Transcriptase Product
Table 42. Bio-Rad Recent Developments
Table 43. Takara Bio Corporation Information
Table 44. Takara Bio Description and Major Businesses
Table 45. Takara Bio Reverse Transcriptase Sales (L), Revenue (US$, Mn) and Gross Margin (USD/ml) (2016-2021)
Table 46. Takara Bio Reverse Transcriptase Product
Table 47. Takara Bio Recent Developments
Table 48. Agilent Corporation Information
Table 49. Agilent Description and Major Businesses
Table 50. Agilent Reverse Transcriptase Sales (L), Revenue (US$, Mn) and Gross Margin (USD/ml) (2016-2021)
Table 51. Agilent Reverse Transcriptase Product
Table 52. Agilent Recent Developments
Table 53. Qiagen Corporation Information
Table 54. Qiagen Description and Major Businesses
Table 55. Qiagen Reverse Transcriptase Sales (L), Revenue (US$, Mn) and Gross Margin (USD/ml) (2016-2021)
Table 56. Qiagen Reverse Transcriptase Product
Table 57. Qiagen Recent Developments
Table 58. Fapon Biotech Corporation Information
Table 59. Fapon Biotech Description and Major Businesses
Table 60. Fapon Biotech Reverse Transcriptase Sales (L), Revenue (US$, Mn) and Gross Margin (USD/ml) (2016-2021)
Table 61. Fapon Biotech Reverse Transcriptase Product
Table 62. Fapon Biotech Recent Developments
Table 63. Toyobo Corporation Information
Table 64. Toyobo Description and Major Businesses
Table 65. Toyobo Reverse Transcriptase Sales (L), Revenue (US$, Mn) and Gross Margin (USD/ml) (2016-2021)
Table 66. Toyobo Reverse Transcriptase Product
Table 67. Toyobo Recent Developments
Table 68. Vazyme Corporation Information
Table 69. Vazyme Description and Major Businesses
Table 70. Vazyme Reverse Transcriptase Sales (L), Revenue (US$, Mn) and Gross Margin (USD/ml) (2016-2021)
Table 71. Vazyme Reverse Transcriptase Product
Table 72. Vazyme Recent Developments
Table 73. New England Biolabs Corporation Information
Table 74. New England Biolabs Description and Major Businesses
Table 75. New England Biolabs Reverse Transcriptase Sales (L), Revenue (US$, Mn) and Gross Margin (USD/ml) (2016-2021)
Table 76. New England Biolabs Reverse Transcriptase Product
Table 77. New England Biolabs Recent Developments
Table 78. Reverse Transcriptase Production Capacity (L) of Key Manufacturers in United States Market, 2019-2021 (L)
Table 79. United States Reverse Transcriptase Capacity Market Share of Key Manufacturers, 2019-2021
Table 80. Reverse Transcriptase Market Opportunities & Trends in United States Market
Table 81. Reverse Transcriptase Market Drivers in United States Market
Table 82. Reverse Transcriptase Market Restraints in United States Market
Table 83. Reverse Transcriptase Raw Materials
Table 84. Reverse Transcriptase Raw Materials Suppliers in United States Market
Table 85. Typical Reverse Transcriptase Downstream
Table 86. Reverse Transcriptase Downstream Clients in United States Market
Table 87. Reverse Transcriptase Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Reverse Transcriptase Product Picture
Figure 2. Reverse Transcriptase Segment by Type
Figure 3. Reverse Transcriptase Segment by Application
Figure 4. United States Reverse Transcriptase Market Overview: 2020
Figure 5. United States Reverse Transcriptase Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Reverse Transcriptase Revenue, 2016-2027 (US$, Mn)
Figure 7. Reverse Transcriptase Sales in United States Market: 2016-2027 (L)
Figure 8. The Top 3 and 5 Players Market Share by Reverse Transcriptase Revenue in 2020
Figure 9. MMLV Reverse Transcriptase Product Picture
Figure 10. AMV Reverse Transcriptase Product Picture
Figure 11. By Type - United States Reverse Transcriptase Sales Market Share, 2016-2027
Figure 12. By Type - United States Reverse Transcriptase Revenue Market Share, 2016-2027
Figure 13. By Type - United States Reverse Transcriptase Price (USD/ml), 2016-2027
Figure 14. PCR
Figure 15. Sequencing
Figure 16. Cloning
Figure 17. By Application - United States Reverse Transcriptase Sales Market Share, 2016-2027
Figure 18. By Application - United States Reverse Transcriptase Revenue Market Share, 2016-2027
Figure 19. By Application - United States Reverse Transcriptase Price (USD/ml), 2016-2027
Figure 20. Thermo Fisher Reverse Transcriptase Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Promega Reverse Transcriptase Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Roche Reverse Transcriptase Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Bio-Rad Reverse Transcriptase Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Takara Bio Reverse Transcriptase Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Agilent Reverse Transcriptase Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Qiagen Reverse Transcriptase Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Fapon Biotech Reverse Transcriptase Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Toyobo Reverse Transcriptase Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Vazyme Reverse Transcriptase Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. New England Biolabs Reverse Transcriptase Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. United States Reverse Transcriptase Production Capacity (L), 2016-2027
Figure 32. Reverse Transcriptase Industry Value Chain
Figure 33. Marketing Channels